| Record ID | ia:anabolictreatmen0000unse |
| Source | Internet Archive |
| Download MARC XML | https://archive.org/download/anabolictreatmen0000unse/anabolictreatmen0000unse_marc.xml |
| Download MARC binary | https://www.archive.org/download/anabolictreatmen0000unse/anabolictreatmen0000unse_meta.mrc |
LEADER: 01133cam 2200325 a 4500
001 97015242 //r97
003 DLC
005 19971209083848.9
008 970416s1998 flua b 001 0 eng c
010 $a 97015242 //r97
020 $a0849385563 (alk. paper)
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aRC931.O73$bA53 1998
060 10 $aWE 250 A532 1997
082 00 $a616.7/16$221
245 00 $aAnabolic treatments for osteoporosis /$cedited by James F. Whitfield, Paul Morley.
260 $aBoca Raton :$bCRC Press,$cc1998.
300 $a266 p. :$bill. ;$c24 cm.
490 1 $aPharmacology and toxicology
504 $aIncludes bibliographical references and index.
650 0 $aOsteoporosis$xHormone therapy.
650 0 $aParathyroid hormone$xTherapeutic use.
650 0 $aSomatomedin$xTherapeutic use.
650 12 $aOsteoporosis$xdrug therapy.
650 22 $aParathyroid Hormones$xtherapeutic use.
650 22 $aProstaglandins E$xtherapeutic use.
650 22 $aFluorides$xtherapeutic use.
700 1 $aWhitfield, James F.
700 1 $aMorley, Paul,$cPh. D.
830 0 $aPharmacology & toxicology (Boca Raton, Fla.)